Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BlossomHill Therapeutics, Inc.
Market Cap
$570.28M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$566.48M
Operating Margin
-156.36%
TTM Avg
-104.91%
3Y Avg
-81.98%
5Y Avg
-81.61%
Market Cap
$564.07M
Operating Margin
46.95%
TTM Avg
-1.63%
3Y Avg
-11705.79%
5Y Avg
-12269.85%
Market Cap
$573.32M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
Market Cap
$586.13M
Operating Margin
-9.01%
TTM Avg
-13.34%
3Y Avg
-16.36%
5Y Avg
-20.24%
Market Cap
$557.41M
Operating Margin
-29.35%
TTM Avg
-5.63%
3Y Avg
-52.07%
5Y Avg
-106.16%
Market Cap
$541.64M
Operating Margin
-1.90%
TTM Avg
-16.29%
3Y Avg
-781.66%
5Y Avg
-851.82%
Market Cap
$602.48M
Operating Margin
40.10%
TTM Avg
33.30%
3Y Avg
-21.49%
5Y Avg
1.14%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $570.28M | 0.00% | 0.00% | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $566.48M | -156.36% | -104.91% | -81.98% | -81.61% |
| CorMedix Inc. (CRMD)vs › | $564.07M | 46.95% | -1.63% | -11705.79% | -12269.85% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $573.32M | -975.91% | -867.04% | -586.91% | -743.36% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $586.13M | -9.01% | -13.34% | -16.36% | -20.24% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.41M | -29.35% | -5.63% | -52.07% | -106.16% |
| Delcath Systems, Inc. (DCTH)vs › | $541.64M | -1.90% | -16.29% | -781.66% | -851.82% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $602.48M | 40.10% | 33.30% | -21.49% | 1.14% |
| Immix Biopharma, Inc. (IMMX)vs › | $540.43M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-03-31 | 0.00% |
